Search

Misook Yu

Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642, 1641
Total Applications
878
Issued Applications
268
Pending Applications
204
Abandoned Applications
408

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 910661 [patent_doc_number] => 07329743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Gene encoding labyrinthin, a marker for cancer' [patent_app_type] => utility [patent_app_number] => 10/830702 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8231 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329743.pdf [firstpage_image] =>[orig_patent_app_number] => 10830702 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/830702
Gene encoding labyrinthin, a marker for cancer Apr 22, 2004 Issued
Array ( [id] => 7202529 [patent_doc_number] => 20050042631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Cloning and characterization of two novel m-RNA transcription factors' [patent_app_type] => utility [patent_app_number] => 10/819860 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28961 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042631.pdf [firstpage_image] =>[orig_patent_app_number] => 10819860 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/819860
Cloning and characterization of two novel m-RNA transcription factors Apr 5, 2004 Abandoned
Array ( [id] => 5759624 [patent_doc_number] => 20060210569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Antibodies inhibiting transportation activity of peptide transporter' [patent_app_type] => utility [patent_app_number] => 10/550987 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6243 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210569.pdf [firstpage_image] =>[orig_patent_app_number] => 10550987 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550987
Antibodies that inhibit transport activity of peptide transporters Mar 25, 2004 Issued
Array ( [id] => 7191724 [patent_doc_number] => 20040204574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'TSA305 gene' [patent_app_type] => new [patent_app_number] => 10/800911 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6614 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204574.pdf [firstpage_image] =>[orig_patent_app_number] => 10800911 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/800911
TSA305 gene Mar 15, 2004 Abandoned
Array ( [id] => 7442331 [patent_doc_number] => 20040163137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'PG-3 and biallelic markers thereof' [patent_app_type] => new [patent_app_number] => 10/468582 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 86366 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20040163137.pdf [firstpage_image] =>[orig_patent_app_number] => 10468582 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468582
PG-3 and biallelic markers thereof Mar 14, 2004 Abandoned
Array ( [id] => 5154267 [patent_doc_number] => 20070037150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Tyrosine kinome' [patent_app_type] => utility [patent_app_number] => 10/544536 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4879 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037150.pdf [firstpage_image] =>[orig_patent_app_number] => 10544536 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544536
Tyrosine kinome Feb 17, 2004 Abandoned
Array ( [id] => 5858759 [patent_doc_number] => 20060228710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Novel therapeutic targets in cancer' [patent_app_type] => utility [patent_app_number] => 10/545777 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 82002 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228710.pdf [firstpage_image] =>[orig_patent_app_number] => 10545777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/545777
Novel therapeutic targets in cancer Feb 16, 2004 Abandoned
Array ( [id] => 5732284 [patent_doc_number] => 20060257401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Sensitizing cells for apoptosis by selectively blocking cytokines' [patent_app_type] => utility [patent_app_number] => 10/544794 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15662 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257401.pdf [firstpage_image] =>[orig_patent_app_number] => 10544794 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544794
Sensitizing cells for apoptosis by selectively blocking cytokines Feb 8, 2004 Issued
Array ( [id] => 7308770 [patent_doc_number] => 20040142395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways' [patent_app_type] => new [patent_app_number] => 10/770725 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23056 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142395.pdf [firstpage_image] =>[orig_patent_app_number] => 10770725 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/770725
Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways Feb 2, 2004 Abandoned
Array ( [id] => 5153926 [patent_doc_number] => 20070036809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Tolerance-induced targeted antibody production' [patent_app_type] => utility [patent_app_number] => 10/542586 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17331 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036809.pdf [firstpage_image] =>[orig_patent_app_number] => 10542586 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/542586
Tolerance-induced targeted antibody production Jan 28, 2004 Abandoned
Array ( [id] => 7386298 [patent_doc_number] => 20040180371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions of a novel serine protease inhibitor' [patent_app_type] => new [patent_app_number] => 10/766778 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 63554 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180371.pdf [firstpage_image] =>[orig_patent_app_number] => 10766778 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/766778
Methods and compositions of a novel serine protease inhibitor Jan 27, 2004 Abandoned
Array ( [id] => 7010259 [patent_doc_number] => 20050063975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/752421 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21515 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20050063975.pdf [firstpage_image] =>[orig_patent_app_number] => 10752421 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/752421
Serpentine transmembrane antigens expressed in human cancers and uses thereof Jan 4, 2004 Issued
Array ( [id] => 52232 [patent_doc_number] => 07771723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Remedies for myeloma to be used together with nitrogen mustard antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/749538 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 12749 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771723.pdf [firstpage_image] =>[orig_patent_app_number] => 10749538 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/749538
Remedies for myeloma to be used together with nitrogen mustard antitumor agents Dec 29, 2003 Issued
Array ( [id] => 474886 [patent_doc_number] => 07226748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease' [patent_app_type] => utility [patent_app_number] => 10/737350 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 39 [patent_no_of_words] => 49759 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226748.pdf [firstpage_image] =>[orig_patent_app_number] => 10737350 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/737350
HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease Dec 14, 2003 Issued
Array ( [id] => 5183492 [patent_doc_number] => 20070054846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Bcl-w structure and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/537635 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28641 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054846.pdf [firstpage_image] =>[orig_patent_app_number] => 10537635 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/537635
Bcl-w structure and uses therefor Dec 2, 2003 Abandoned
Array ( [id] => 5119935 [patent_doc_number] => 20070141649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Loc169505 as modifiers of the apc and axin pathways and methods of use' [patent_app_type] => utility [patent_app_number] => 10/535444 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16255 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141649.pdf [firstpage_image] =>[orig_patent_app_number] => 10535444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/535444
Loc169505 as modifiers of the apc and axin pathways and methods of use Nov 23, 2003 Abandoned
Array ( [id] => 559725 [patent_doc_number] => 07470721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways' [patent_app_type] => utility [patent_app_number] => 10/712850 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 37 [patent_no_of_words] => 22866 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470721.pdf [firstpage_image] =>[orig_patent_app_number] => 10712850 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/712850
Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways Nov 12, 2003 Issued
Array ( [id] => 7045508 [patent_doc_number] => 20050250103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 10/705944 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6763 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250103.pdf [firstpage_image] =>[orig_patent_app_number] => 10705944 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/705944
Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents Nov 12, 2003 Abandoned
Array ( [id] => 7407753 [patent_doc_number] => 20040106143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Monoclonal antibody against estrogen stimulated leucine aminopeptidase' [patent_app_type] => new [patent_app_number] => 10/705991 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8299 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106143.pdf [firstpage_image] =>[orig_patent_app_number] => 10705991 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/705991
Monoclonal antibody against estrogen stimulated leucine aminopeptidase Nov 11, 2003 Abandoned
Array ( [id] => 5842060 [patent_doc_number] => 20060120959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof' [patent_app_type] => utility [patent_app_number] => 10/532446 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6330 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20060120959.pdf [firstpage_image] =>[orig_patent_app_number] => 10532446 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/532446
Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof Nov 9, 2003 Abandoned
Menu